myocardial infarction (Wilhelmson et al. 1974 , Multicentre International Study 1975 . This might be due to reduction in the incidence of ventricular arrhythmias and more studies are needed to determine whether this effect is mediated through metabolic pathways.
Conclusion
Myocardial ischemia induces an energy crisis in my9cardial cells. If this can be corrected early enough by metabolic intervention designed to provide an optimum balance of substrates for myocardial metabolism, the serious consequences of extending myocardial ischmmic damage and of ventricular arrhythmias might theoretically be reduced.
Reduction of plasma FFA and of their extraction from arterial blood by the myocardium is associated under experimental conditions of myocardial ischkmia with reduction of the extent of ischiemic damage. Similarly, increased glucose utilization or availability has the same effect.
Clinical and experimental evidence has indicated an association between raised plasma FFA levels and the development of serious ventricular arrhythmias and, recently, a controlled trial during which reduction of plasma FFA concentrations was achieved and led to significant reduction of serious ventricular arrhythmias in patients treated within five hours of the onset of symptoms of myocardial infarction.
Metabolic intervention is a logical development for the management of acute myocardial ischoemia and may have a large therapeutic potential. The effect of antiarrhythmic drugs on the heart can largely be explained on the basis of their effects on cellular electrophysiology.
From the electrical standpoint, there are two types of cardiac cells, automatic or pacemaker cells, and contractile muscle cells. Resting muscle cells have an intracellular potassium concentration some 30 times that of the extracellular concentration, whereas intracellular sodium is only about 4% of the extracellular sodium. This ionic imbalance, which is maintained by the 'sodium pump' function of the cell membrane leads to a difference in electrical potential across itthe resting membrane potential. In ventricular cells, the interior of the cell is some 90 mV negative relative to the exterior. When the cell is stimulated, membrane permeability is increas1ed so that sodium ions enter the cell. This reduces the membrane potential; when this reaches a certain level ('threshold potential') further changes take place in membrane permeability that allow a further rapid influx of sodium \accompanied by a slower influx of calcium.
Extremely rapid depolarization 'results, the interior of the cell transiently becoming positive relative to the exterior (Phase 0 of the action potential). This phase is followed by repolarization (Phases 1, 2 and 3) which proceeds until the previous resting membrane potential is reached (Phase 4). In the working myocardial cell, this level is maintained until a further stimulus arrives.
In a pacemaking cell, diastole is not stable; a slow leak of sodium into the cell during this time produces slow depolarization. When threshold potential is reached, the cell spontaneously depolarizes. Current now flows from this excited cell to adjacent resting cells because of the difference in potential. These in turn become excited and act as a source for a further spread of current.
The rate of rise and the amplitude of the upstroke (Phase 0) of the action potential is determined by the membrane potential at the time that it is elicited. The larger the membrane, potential, the faster the rate of rise and the larger the amplitude. The faster the rate of rise, the faster adjacent cells reach threshold; the greater the amplitude the larger the area brought to threshold. During Phases 1 and 2 the cell is absolutely refractory to stimulation. When it is partially depolarized, as in Phase 3, it is relatively refractory; an action potential which is elicited at this time will be smaller and more slowly rising than normal. It will therefore be conducted at a slower speed.
The automatic cells with the most rapid rate of spontaneous depolarization normally dominate the heart as the pacemaker. These are usually situated in the sinus node. Ectopic rhythms, in which the heart is activated from a source other than the sinus node, arise from a variety of mechanisms: Escape of lower centres: If the sinus node is depressed, the role of pacemaker may be assumed by the junctional tissue in the neighbourhood of the AV node or elsewhere.
Increased automaticity ofother zones: Other pacemaker tissue may develop more rapid spontaneous diastolic depolarization as a result of such factors as ischxmia, electrolyte disorders and digitalis intoxication.
Re-entry or circus movement: When there are adjacent areas of myocardium with differing refractory periods, a single impulse may lead to repeated excitation of an area of myocardium. Thus, an impulse may activate an area which has recovered from a previous cycle, but cannot enter a zone which is still refractory. Subsequently, the impulse may reach this tissue, now recovered, by a different route and thus stimulate it. This tissue may act as a pathway back to the initially activated area which, if it has recovered, may accept Table I Classification of antiarrhythmic drugs (Vaughan Class 1 Class 2 Class 3 Class 4 (slows rate of (anti-(prolongs (calcium rise ofPhase 0) sympathetic) action potential) antagonist) Quinidine
Beta-blockers Amiodarone Verapamil Procainamide Bretylium Sotalol Lignocaine Bretylium Mexiletine Quinidine Phenytoin Procainamide Some betablockers the impulse again. In order for there to be time for recovery to take place, the re-entrant pathway must either be long or conduction must be extremely slow and the refractory period short. Drugs which accelerate conduction or prolong the refractory period will block re-entry.
The actions of antiarrhythmic drugs are complex but Vaughan has divided the types of antiarrhythmic drug action into four classes (see Table 1 ). This extremely useful classification has largely been based on studies of isolated atrial muscle and therefore does not take into account such factors as drug metabolism and protein binding, or the different effects exerted on automatic and muscle cells or on the different types of conducting tissue.
Class 1 agents are characterized by their 'membrane stabilizing' effect. They slow the rapid inflow of sodium during Phase 0 and therefore reduce the maximum rate of depolarization. They also show spontaneous Phase 4 depolarization in pacemaking tissue. They may therefore both reduce pacemaker activity and slow conduction.
Quinidine is the archetype of this type of drug but also has other important effects. It prolongs the effective refractory period and lowers the membrane potential at which a stimulus can activate a propagated impulse. It may lead to sinus arrest, sino-atrial block, AV conduction defects, bundle branch block and an increase in the QT interval. However, it also has a vagolytic effect which can cause transient sinus tachycardia and accelerate AV conduction; this accounts for the finding in 2:1 atrial flutter that the ventricular rate increases as the atrial rate falls. Quinidine is effective in both supraventricular and ventricular arrhythmias and is perhaps the most potent of all antiarrhythmic drugs. Procainamide closely resembles it in its antiarrhythmic actions; it is possibly more effective in ventricular arrhythmias and relatively less so in the atrial tachycardias.
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Lignocaine resembles quinidine and procainamide in its effect on depolarization in Phase 0 and Phase 4 but differs in that it does not prolong the action potential or the effective refractory period. Mexiletine (Allan et al. 1972 , Singh & Vaughan Williams 1972a ) has a similar mode of action.
The other main antiarrhythmic drugs fall into Class 2. These have antisympathetic effects; the most important sub-group are those that block beta-adrenoreceptor sites. Some of these drugs, notably practolol and acebutolol, also have some intrinsic sympathomimetic activity. Propranolol, oxprenolol and pindolol also have a Class 1 action, but it is doubtful whether this is of any clinical importance. Of more practical significance is the cardio-selectivity of certain drugs in this group. Practolol and acebutolol have little effect on the bronchi compared with propranolol and oxprenolol and are therefore safer to use in patients with obstructive airways disease. In large doses, beta-adrenergic blocking drugs can block AV conduction by affecting AV junctional tissue and the bundle of His, but do not usually cause block in the lower conducting tissue.
Class 3 compounds prolong the action potential and refractory period of atrial and ventricular muscle. Amiodarone is the only currently available drug which has this as its main antiarrhythmic effect (Charlier et al. 1968 , Singh & Vaughan Williams 1970 . It has proved to be more effective in atrial than in ventricular arrhythmias and is particularly valuable in preventing reciprocating tachycardias of the Wolff-Parkinson-White type. Verapamil appears to have a different mode of action from any of the previously mentioned drugs and has been placed in a fourth class by Singh & Vaughan Williams (1972b) . It appears to interfere with the inward calcium current which is the major component in depolarization in fibres in certain specific sites, notably the atrioventricular (AV) node. Therapeutically, its ability to block atrioventricular conduction in the AV node is valuable in the treatment of reciprocating tachycardias. Data made available by electrophysiological studies make more rational treatment of arrhythmias possible. Unfortunately, as we frequently do not know whether an arrhythmia is due to re-entry or to enhanced automaticity and as, furthermore, the same drug under different circumstances may produce different electrophysiological effects, therapy remains to a considerable extent empirical.
